DURMO, REXHEP
 Distribuzione geografica
Continente #
NA - Nord America 168
EU - Europa 76
AS - Asia 45
Totale 289
Nazione #
US - Stati Uniti d'America 167
CN - Cina 22
IT - Italia 18
UA - Ucraina 15
HK - Hong Kong 14
DE - Germania 12
GB - Regno Unito 9
SG - Singapore 7
IE - Irlanda 6
FI - Finlandia 5
SE - Svezia 5
FR - Francia 3
RU - Federazione Russa 3
ID - Indonesia 2
CA - Canada 1
Totale 289
Città #
Fairfield 33
Woodbridge 16
Hong Kong 14
Ashburn 13
Jacksonville 13
Cambridge 11
Ann Arbor 10
Beijing 10
Princeton 10
Seattle 10
Wilmington 9
Houston 8
Dublin 6
New York 6
Singapore 6
Helsinki 5
Brescia 4
Chandler 3
Des Moines 3
Shanghai 3
Nanjing 2
Shenyang 2
Surabaya 2
Tianjin 2
Vobarno 2
Augusta 1
Esslingen am Neckar 1
Frankfurt am Main 1
Hebei 1
Jinan 1
Kunming 1
Los Angeles 1
Richmond 1
San Diego 1
San Francisco 1
Toronto 1
Totale 214
Nome #
18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved—A Critical Review 72
18F-FMISO PET imaging: insights over MRI in patients with glioma 66
Three years’ clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer 50
Improvement of diagnostic accuracy of 18fluorine-fluorodeoxyglucose PET/computed tomography in detection of infective endocarditis using a 72-h low carbs protocol 46
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study 29
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients 21
The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience 12
Totale 296
Categoria #
all - tutte 2.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 0 0 8 20 14 18 11 3
2020/202186 8 7 6 9 6 8 0 13 4 9 8 8
2021/202242 10 1 0 2 1 7 0 3 1 4 3 10
2022/202323 5 1 0 1 0 9 0 0 3 0 2 2
2023/202471 6 14 8 1 4 8 1 0 14 1 1 13
Totale 296